Denise R Aberle, Sarah DeMello, Christine D Berg, William C Black, Brenda Brewer, Timothy R Church, Kathy L Clingan, Fenghai Duan, Richard M Fagerstrom, Ilana F Gareen, Constantine A Gatsonis, David S Gierada, Amanda Jain, Gordon C Jones, Irene Mahon, Pamela M Marcus, Joshua M Rathmell, JoRean Sicks
BACKGROUND: The National Lung Screening Trial was conducted to determine whether three annual screenings (rounds T0, T1, and T2) with low-dose helical computed tomography (CT), as compared with chest radiography, could reduce mortality from lung cancer. We present detailed findings from the first two incidence screenings (rounds T1 and T2). METHODS: We evaluated the rate of adherence of the participants to the screening protocol, the results of screening and downstream diagnostic tests, features of the lung-cancer cases, and first-line treatments, and we estimated the performance characteristics of both screening methods...
September 5, 2013: New England Journal of Medicine